Point of Care (POC) Drugs of Abuse Testing Market to account from USD 1625.14 million in 2020 to USD 2311.12 million by 2028

Global point of care (POC) drugs of abuse testing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 1625.14 million in 2020 to USD 2311.12 million by 2028 growing at a CAGR of 4.50% in the above-mentioned forecast period.

Request Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-poc-drugs-of-abuse-testing-market

Drugs of abuse is basically the illegal prescribed substances consumed for a non-medical purpose. The point of care (POC) drugs of abuse testing deals with the detection of illegal substances in the urine, blood, saliva, hair or sweat which is done at a specified testing location rather than the sample being sent to a laboratory.

The high prevalence of drug abuse in individuals especially teenagers and the usage of point of care drugs of abuse testing in sports are primarily driving the growth of the point of care (POC) drugs of abuse testing market. Additionally, the known advantages of point of care drugs of abuse testing such as reduced potential for contamination or deterioration, fewer requirements to aliquot specimens or store samples and portability are the reason for high adoption and usage of point of care (POC) drugs of abuse testing. On the other hand, the point of care testing devices may not be as reliable and accurate as compared to the laboratory-based testing’s due to high probability of falser positive or negative results which might restrain the overall growth of the market. The increasing number of regulatory approvals for and the rising usage of home-based point of care devices is estimated to generate new opportunities within the forecast period.

Request for TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-point-of-care-poc-drugs-of-abuse-testing-market

Global Point of care (POC) Drugs of Abuse Testing Market Scope and Market Size

Point of care (POC) drugs of abuse testing market is segmented on the basis of drugs type, product, sample type and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of drugs type, the point of care (POC) drugs of abuse testing market is bifurcated into amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, opiates and phencyclidine.
• On the basis of product, the market is segmented into analysers, rapid testing devices and consumables. Analysers are further segmented into immunoassays, chromatographic devices and breath analysers. Rapid testing devices are further segmented into urine testing devices and oral fluid testing devices.
• On the basis of sample type, the market is segregated into saliva, urine, blood and others.
• On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, forensic laboratories and others.

Point of care (POC) Drugs of Abuse Testing Market Country Level Analysis

Point of care (POC) drugs of abuse testing market is analysed and market size insights and trends are provided by drugs type, product, sample type and end-user as referenced above.

Inquiry Before Buy @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-point-of-care-poc-drugs-of-abuse-testing-market

The countries covered in the point of care (POC) drugs of abuse testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Competitive Landscape and Point of care (POC) Drugs of Abuse Testing Market Share Analysis

Point of care (POC) drugs of abuse testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point of care (POC) drugs of abuse testing market.

The major players covered in the point of care (POC) drugs of abuse testing market report are uest Diagnostics Incorporated, Abbott, AdvaCare Pharma, Cliawaived Inc., DRUGSCAN, Millennium Health, BD, Agilent Technologies Inc., Danaher, Bio-Rad Laboratories Inc., Cellavision, JOYSBIO (Tianjin) Biotechnology Co., Ltd, NIHON KOHDEN CORPORATION, Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Sysmex Corporation, Merck KGaA, Cardinal Health, Takara Bio Inc., bioMérieux SA, Enzo Life Sciences Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.